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| INTRODUCTION
Food allergy (FA) appears in diverse clinical patterns, typically involving the cutaneous, gastrointestinal, respiratory and cardiovascular systems. 1 Besides observable clinical signs, many patients and parents also report subjective symptoms. Infants may present with being uncomfortable or crying and preschool children may present with food refusal, unable to adequately express specific symptoms. A causal link to a trigger food is usually suspected when signs or symptoms occur within 2 hours of ingestion but delayed appearance is sometimes observed, for example worsening of eczema and gastrointestinal symptoms. The heterogeneity of FA impedes the development of a simple, comprehensive diagnostic workup. [2] [3] [4] [5] Clinical evaluation of FA is usually set in motion based on a suggestive medical history, sometimes complemented through a prospective dietician-supervised elimination diet. When the diagnosis is based only on self-reported symptoms or objective signs, a high number of healthy individuals are labeled food allergic. 6, 7 Objective assessment of sensitization (eg, skin prick test, allergen-specific immunoglobulin E) is considered to be the first step toward a more objective case definition, 1, 8 but only challenge testing can verify the etiologic role of a suspected food. 9 Current guidelines describe double-blind, placebo-controlled food challenges (DBPCFC) as the highest diagnostic standard. 4, 8, 10 Variability The impact of personal experience and subjective appraisal of the clinical appearance on the diagnostic interpretation of blinded food challenges has rarely been examined. [11] [12] [13] Using data from singleprotocol DBPCFCs conducted within the multicenter EuroPrevall birth cohort, [14] [15] [16] we aimed to compare challenge outcomes as defined by the experienced and trained study physicians with those based on detailed documented signs and symptoms. Our goal was to identify areas, which could be improved further to support comparability, including techniques used for challenge documentation and interpretation, and diagnostic algorithms to improve the current gold standard for a robust diagnosis of FA.
| METHODS

| Setting and participants
The EuroPrevall birth cohort set out to estimate the frequency and factors influencing the onset and duration of FA in 9 study centers in 9
handling of the protocols. Suspected food allergy was clinically evaluated by doubleblind, placebo-controlled food challenges using a nine dose escalation protocol. The primary challenge outcomes based on physician's appraisal were compared to documented signs and symptoms. 
| Food challenges
The unit of observation for this analysis was a complete challenge including one food (verum) and a corresponding placebo control day. A single placebo day may have served as a control for more than one food in question. Two challenge days were randomly allocated to test food or placebo. Challenge and placebo days were at least 48 hours apart. Children were fed 9 incremental doses in 20 minute intervals under clinical supervision. 14 The procedure was stopped at the discretion of the supervising physicians. All physicians were trained in the food challenge protocol for this study to harmonize the identification of objective signs and symptoms warranting the discontinuation of the challenge. However, as food allergy has very diverse appearances, it was not possible to formally define all indications for stopping the challenge, in particular in light of the patient's safety. The assessment was unblinded after completion of the last challenge day.
In this analysis, we compared three different challenge-based definitions of food allergy, described in the following paragraphs.
| Physician's judgment of challenge outcome
For the first definition (physician's judgment), study physicians assigned outcomes (positive, negative) for each challenge day and then concluded an overall judgment after unblinding. This overall conclusion was the first definition of food allergy used. Patients were judged to be clinically tolerant (both days negative), allergic (test food positive, placebo negative), placebo reactors (test food negative, placebo positive), or inconclusive with regard to food allergy (both days positive).
| Restrictive cutoff for challenge outcome
For the other two definitions of food allergy, clinical observations were recorded through a standardized record form with separate sections for each challenge step recording immediate and delayed (≥2 hours) reactions. Besides skin assessment (SCORAD
18
) and vital parameters before and after the challenge, 19 specific signs and symptoms were collected as dichotomous traits (present or absent).
Two different cutoff criteria were used to derive sign-and symptombased challenge outcomes. After the judgment of the study physician was recorded, the restrictive cutoff (second definition of food allergy)
to call a challenge positive was derived, limited to immediate urticaria, angioedema, flush, emesis, diarrhea, respiratory symptoms, immediate or late worsening of eczema with an objective SCORAD increase ≥10, and cardiovascular symptoms (never observed in this population).
| Permissive cutoff for challenge outcome
The permissive cutoff (third definition of food allergy) additionally included reactions occurring more than 2 hours after the challenge (called delayed) and less pronounced worsening of eczema (SCORAD increase of 5 or more).
| Statistical methods
Calculations were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Missing data was rechecked against the initial study 19 ) was calculated only for subsamples large enough to report robust proportion estimates (20 + reactive challenges for a single center).
| RESULTS
| Challenge outcomes
A total of 839 valid food challenges (verum-placebo pairs) were conducted in the EuroPrevall birth cohort. Although study centers were similar in size (976 to 1570 participants), they reported widely differing numbers of procedures (7 to 219). Based on study physician's judgment (first definition of challenge-based food allergy), 317 (38.8%) challenges resulted in the diagnosis "allergic" due to a positive outcome on the verum day and a negative outcome on the placebo day. Cow's milk and hen's egg were the most frequent foods in question. Percentages of confirmed FA varied between centers (26.1% to 80.0% of conducted challenges). The proportion of allergic to challenged children was similar across different ages. Challenges with positive placebo day (placebo reactors and inconclusive food challenges) were unequally distributed between centers, with a maximum of 16 procedures in center C. Twenty-eight of all 45 (62.2%) challenges with a positive placebo day were related to cow's milk, with a trend toward younger ages (Table 1) .
| Challenge signs and symptoms
A total of 334 of 839 (39.8%) verum (test food) challenge days were stopped before starting the final dose, of which most instances were judged positive by physicians. Urticaria (30.9%), flush (29.4%), and respiratory signs or symptoms (36.8%) were the most frequent reasons to stop challenges at lower doses (after step 1 to 4), accompanied by subjective gastrointestinal symptoms in 35.3% (not always considered as stop criterion on its own, Table 2 Figure S1 ).
| Sign-and symptom-based outcomes vs physician's appraisal
The agreement between sign-and symptom-based challenge day outcomes using the restrictive cutoff (considered as stopping criteria in the study protocol) and physician's judgment/diagnosis varied between study centers, with the lowest agreement in center C yielding a 
| DISCUSSION
| Main results
There were differences between centers comparing physician's appraisal and sign-and symptom-based outcomes recorded during blinded food challenges of infants and young children up to the age of 2 years within the multicenter EuroPrevall birth cohort study. The agreement between the permissive cutoff and physician's appraisal was higher compared to the restrictive criteria, indicating a tendency for study physicians to apply a rather permissive decision threshold. 
Study center
The wide range of positive challenge outcomes between centers (15.6% to 53.6%) might either be due to a real difference in disease 
| Recommendations
Development and standardization of current guidelines and challenge considerably and must not be ignored in study protocols. Here, comparability and restrictive case definitions outweigh the usual "don'tmiss-any" approach, which is appropriate for individual care, where a false positive is a safer misclassification than a false negative.
As was done in this study, preparation and distribution of test food and placebo substrate should be centralized and off-site in research settings, ensuring a high degree of blinding. Unblinding must be delayed until after the challenge documentation has been closed and, as is suggested to assess allocation concealment in clinical trials, blinding success should be documented by assessing participant's and study personnel's guessed allocation of each of the challenge days.
Secondly, already proposed but usually not implemented, 5 all signs and symptoms should be quantified using appropriate measures such as size, distribution, and severity for skin manifestations beyond eczema, or amount and kind of vomit and diarrhea. Moreover, F I G U R E 3 Agreement between study physician's judgment and symptom profile, using different symptom cutoffs (restrictive, permissive). Comparison of single day outcomes (test food and placebo). Asymptotic 95% confidence intervals, 4 of 9 study centers omitted due to low numbers of challenges Thirdly, after closing data entry, a centralized evaluation scheme could assign the final challenge outcome based on recorded signs and symptoms, with the need to register its technical implementation as a medical device. Personnel on site should be asked to label observations they suspect to be causally linked to the ingested food, be it the allergen or placebo. Challenge outcome and day allocation (unblinding) could then be finally returned to the clinical site.
Finally, using a generic online platform for research as well as individual care settings may facilitate data entry, for example, ensuring that data entry for each challenge day was closed before starting the next day, and allowing on-time queries and electronic evaluation of challenge outcomes. Such an algorithm could be asked to return a binary decision (tolerant/reactive) using a rather loose cutoff with the intent to not miss any FA. It may at the same time report quantified severity of the reaction using other cutoffs, ultimately improving comparability between physicians, clinical sites, and countries.
Improving challenge guidelines is recommended to incorporate
what we have demonstrated in this single-protocol, multicenter project, which could also be expected to be beneficial for regular patient care and other research settings.
| Strengths and limitations
As the current gold standard, blinded food challenges cannot be calibrated against another diagnostic test. Therefore, we used the ideal setting of a large single-protocol, multicenter research project to indirectly identify potential shortcomings of its diagnostic capabilities.
Given stability of study personnel over time, heterogeneity of study centers in terms of initial experience with food challenges and different societal backgrounds between centers has allowed us to assess the influence of subjective (often undefined or not accessible)
parameters, but we had no estimates for the individual experience of participating physicians. With the lack of comparable prior knowledge about disease frequency and distribution of potential subtypes of FA in participating countries, we were not able to directly separate true from factitious intercenter differences. We cannot prove that these differences indicate the influence of subjective parameters within this project alone or are rather due to possible disease heterogeneity, but with the procedural aspects identified here accounted for in future research, we will be closer to a true gold standard. Of note, the study was neither designed nor powered for the presented analyses.
| Conclusion
There is no methodology to assess the accuracy and other diagnostic characteristics of blinded food challenges directly. We demonstrated differences between centers of the multicenter EuroPrevall project in terms of overall reactivity to challenges, placebo reactions, and most importantly decision thresholds for assigning challenge outcomes based on physician's judgment. Despite using the same robust, highest standard challenge protocol, these discrepancies suggest there can still be a residual influence of subjective and other non-standardized parameters, threatening valid comparison of results between centers, if challenge outcome is not based on objective signs.
We recommend centralized provision of allergens for food challenges, implementation of detailed sign and symptom quantification, and timely documentation in standardized challenge record forms and that only pre-agreed sign-and symptom-based challenge outcomes derived by unified algorithms should be relied upon. These allow for continuous severity grading in addition to the usual dichotomous challenge outcome and provide valuable information for inter-and within-study comparisons. The school-age follow-up (iFAAM) of the EuroPrevall project implemented these recommendations using case report forms that are publicly available (CRFs, 24 ). Accounting for these recommendations will further improve the diagnostic gold standard of blinded food challenges for food allergies. 
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